Lab automation systems for faster scientific breakthroughs

5 Feb 2018

PAA showcases its complete range of automation solutions, suitable for any type of laboratory or application, at SLAS2018.

Peak Analysis & Automation (PAA) is showcasing its complete range of fully integrated laboratory automation systems (booth 1529 at SLAS2018), San Diego, CA, US. These include PAA’s established S-CEL robotic systems which provide a flexible design to accommodate all types of laboratory automation applications, as well its new S-LAB automated plate handler and GX collaborative robot, together with the proven Overlord scheduling software.

Lab automation systems for faster scientific breakthroughs
PAA showcases its most complete range of laboratory automation solutions at SLAS2018.

S-CEL robotic systems combine modular configuration, containment options and environmental control to make a comprehensive, integrated laboratory automation solution. The company has developed bespoke S-CEL systems for life science research and drug discovery applications in biotech, pharma and academic facilities and is expanding its S-CEL capabilities in the US, supported by its extensive US-based team.

At the other end of the automation spectrum, PAA will be demonstrating the capabilities of its new S-LAB automated plate handler. With super-easy set-up and a highly affordable price-point, S-LAB is an entry-level system that will enable the automation of assays which might not have been considered for automation before. Compatible with up to 300 different instruments and able to handle lidded plates reliably for sterile assays, the S-LAB is the perfect answer for laboratories looking to upscale workflows.

PAA’s GX fully collaborative benchtop robot was demonstrated as a prototype in 2017, and having recently been awarded a CE mark, is now available in both the US and Europe. The GX offers unique 360° continuous rotation of all joints and a barcode reader, delivering unmatched performance, ease of use and safety in the laboratory.

Rob Harkness, Business Development Manager at PAA, said, “This is the first time that we’ve been able to offer such a complete range of automation solutions, suitable for any type of laboratory or application. Our S-CEL robotic systems are allowing organisations to automate highly complex research requirements and S-LAB will make automation a possibility for groups who won’t have considered it before. Either way, we’re keen to talk with anyone who would like to enable faster scientific breakthroughs.”

Read More

Related news

New formulation modelling successes using ex vivo tissue

New formulation modelling successes using ex vivo tissue

9 Oct 2018

One study uses the company's proprietary TurChub model, to evaluate the diffusion and subsequent activity of drugs in human nails.

Read more 
Three-way collaboration to advance gene therapy

Three-way collaboration to advance gene therapy

4 Oct 2018

Partnership aims to increase the robustness and reduce costs for the manufacturing of AAV vectors.

Read more 
New oral treatment for metastatic melanoma receives EU authorisation

New oral treatment for metastatic melanoma receives EU authorisation

24 Sep 2018

Encorafenib in combination with binimetinib demonstrated 14.9 months median progression-free survival compared with vemurafenib monotherapy (7.3 months).

Read more 
Plasticell wins military contract to develop regenerative medicines for the battlefield

Plasticell wins military contract to develop regenerative medicines for the battlefield

4 Sep 2018

Company to use its combinatorial stem cell screening platform to develop technologies for the conversion of pluripotent stem cells into platelets.

Read more 
New biopharmaceutical testing laboratory to open in Geneva

New biopharmaceutical testing laboratory to open in Geneva

28 Aug 2018

SGS's expansion will enable the service provider to offer a full ICH Q6B physico-chemical characterization of biological products.

Read more 
Exosome isolation manufacturing and characterization

Exosome isolation manufacturing and characterization

13 Aug 2018

New service to reliably and reproducibly isolate exosomes from almost any biofluid.

Read more 
Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

8 Aug 2018

Company moves away from manual processing in favour of automated, scalable platforms.

Read more 
A new era for migraine patients

A new era for migraine patients

6 Aug 2018

EU approves Novartis's Aimovig, a first-of-its-kind treatment specifically designed for migraine prevention.

Read more 
WuXi STA and Antengene sign development and manufacturing agreement

WuXi STA and Antengene sign development and manufacturing agreement

24 Jul 2018

WuXi STA chosen for its end-to-end CMC platform for new drug development.

Read more 
ProBioGen and Pionyr initiate 2nd immuno-oncology contract development and manufacturing project

ProBioGen and Pionyr initiate 2nd immuno-oncology contract development and manufacturing project

18 Jul 2018

Parallel cell line development and analysis will allow for optimal cell line selection while compressing the development timeline.

Read more